Envista Holdings Corporation (NVST): Valuation
TTM figures as of July 3, 2026
Envista Holdings Corporation trades at 43.2 times trailing earnings and a 6.05% free-cash-flow yield. On P/E that is higher than 61% of its own month-end history back to 2019. The Healthcare median P/E is 22.9.
Earnings yield 2.31%. ROIC 4.0%. Piotroski F-score 7 of 9. Net debt $310.7M.
84 month-end valuation observations are on file, starting September 2019.
Sector comparison uses 2682 Healthcare names.
Frequently asked questions
Is NVST cheap versus its own history?
Envista Holdings Corporation trades at 43.2 times trailing earnings and a 6.05% free-cash-flow yield. On P/E that is higher than 61% of its own month-end history back to 2019. The Healthcare median P/E is 22.9.
What is NVST's free-cash-flow yield?
Envista Holdings Corporation currently yields 6.05% of market cap as trailing free cash flow.
Where do these valuation figures come from?
Yields and quality metrics are computed from the same SEC TTM figures as the financials page, against the live market cap. Historical bands reconstruct month-end market cap from split-adjusted closes and the share count in the units it was filed, then divide by those dollar totals. Nothing here is a third-party estimate.